Physician Resolve On Display as the Immigration Conversation Continues
New immigration policies are affecting the health of thousands of migrant children, and physicians want the world to know about it.
Read More
Do Patients Really Know What Physicians Do?
Misconceptions linger, and they’re not helping anyone.
Should Physicians "Get So Political" About Gun Violence?
Gun violence is an epidemic in the US, but research remains underfunded compared to other leading causes of mortality.
The Best #TipsForNewDocs Tweets Showcase MedTwitter's True Worth
Those who tweet under the hashtag offer up free advice that can cost thousands of dollars elsewhere, either through CME credits or in medical school.
Hossein Ameri, MD: Will CRISPR Fix Retinitis Pigmentosa?
Following the novel gene-editing tech's approval for the treatment of cancer last year, researchers at Roski Eye Institute are exploring its potential to treat ophthalmic disease.
Lan Yue, PhD: Will Nanophotoswitches One Day Restore Sight to the Blind?
Nanophotoswitches have demonstrated promising results in rats. Will they one day improve transduction in damaged eyes, and restore lost vision in humans?
Jennifer Sun, MD: Why Ophthalmologists Need Machine Learning
The burden of ophthalmic disease is rising. How can ophthalmologists rise to meet it?
Real-World Study Suggests DME Patients Receive Suboptimal Anti-VEGF Dosing
75% of patients with newly-diagnosed, treatment naïve DME received no treatment within 1 year of diagnosis.
Hopkins Researchers Grow Attendance to Free Eye Care Screens 152% Using Vouchers
Researchers hypothesized that making eye care screens free also reduced perceived value of the services.
DRCR's Anti-VEGF Treatment Algorithm Improves PDR Outcomes at 2 Years
The majority of eyes treated in the DRCR Protocol S study had resolved, stable or improved NV at each follow-up visit.
Paolo Silva, MD: Deep Learning Algorithm Predicts Future DR Severity
The algorithm identified PPL-HMA in 20% of eyes and was associated with a 2-3 fold increased risk of DR progression, development of PDR and receipt of intravitreal injections over 4 years.
Algorithm Detects Diabetic Retinopathy in Retinal Images with 97% Accuracy
The deep learning algorithm was tested on 71,000 images, and offers the potential to significantly increase the speed at which DR can be identified.
Outcomes Worse with Anti-VEGF than PRP in Patients Lost to Follow-Up
Eyes that received only anti-VEGF experienced significantly worse visual acuity from initial visit to final visit.
Jason Hsu, MD: Tackling Treatment Adherence in Patients with Diabetic Retinopathy
Anti-VEGF and pan-retinal photocoagulation can be effective, but neither are "one-and-done" therapies. Physicians must be proactive about how they handle patients with PDR.
Another Abuse-Deterrent Opioid Gets FDA Review, Despite Much Evidence That They Work
Remoxy ER is a thick, sticky, high-viscosity capsule formulation designed to deter abuse via injection, snorting and smoking.
Varicose Veins Increase Risk of Deep Venous Thrombosis, Pulmonary Embolism, Peripheral Artery Disease
Varicose veins were rarely thought to have severe health effects, but should now be monitored closely, new evidence suggests.
Prenatal Exposure to Antiepileptic Valproate Linked to Lower Test Scores Years Later
The medication has also been linked to increased risk of autism and reduced IQ.
Medtronic Gets FDA Clearance for Device that Restores Blood Flow During Ischemic Stroke
The device's approval is the first of 2018 for Medtronic, who received agency clearance for 9 devices in last year.
FDA Crackdown on Unapproved Stem Cell Therapies Starts with American CryoStem
Unapproved stem cell therapies now bring in $2.4 billion per year. The FDA is working to ensure they follow regulatory, safety and efficacy guidelines.
Surgeons Suffer from Highest Rate of Work-Related Musculoskeletal Disorders, Pain
Interventions are lacking for MSDs, which can result in lost time at work and early retirement.
Luxturna Carries Potential to Correct Blindness, $850k Price Tag
Spark Therapeutics CEO Jeff Marrazzo reassured patients and the medical community he has an obligation to ensure access to the novel gene therapy.
AVATAR Therapy for Auditory Hallucinations: If You Can't Beat the Voices, Join Them
A new study suggests the novel therapy can help empower patients with psychoses.
Children Whose Parents Have Been Homeless Are Twice as Likely to Have Psychiatric Disorders
Risks increase when a child’s mother, versus their father has a history of homelessness.
Early Initiation of ART Could Minimize Cognitive Decline in Patients With HIV
New evidence suggests HIV’s toll on the brain occurs very early in infection.
Physicians Want Improved Procedures for Referring to Home-Based Care
Referral pathways could help reduce patient admissions to hospitals, a new study suggests.
Younger Ophthalmologists Twice as Likely to Receive Patient Complaints
Patients mostly concerned with diagnosis, recommendation, and medication issues, as well as doctor availability.
Injectable Buprenorphine Sublocade Gets FDA Nod, Black Box Warning for Opioid Use Disorder
The approval marks the start of an agency effort to facilitate approvals of medication assisted treatment.
Amgen/Novartis's Erenumab (Aimovig) Posts Positive Phase 3 Results in NEJM
The FDA has set a Prescription Drug User Fee Act target date for May 17, 2018.
Hospital Readmissions Reduction Program Increases Mortality in Heart Failure Patients
New evidence suggests the program has reversed a decades-long trend of reduced HF mortality.
Emicizumab Gets FDA Greenlight for Treatment of Hemophilia A
87% of pediatric patients did not experience a bleeding episode that required treatment during phase 3 trials.